Organization
Switzerland
11 abstracts
Abstract
Adjunctive statistical standardization of quantitated adjuvant ER and PgR in CCTG MA.27.Org: Ontario Institute for Cancer Research, Toronto, ON, Canada, MASS General Hospital BHX-1, Mayo Clinic Department of Oncology, Progendis, Caris Life Sciences,
Abstract
Updated results of the INTELLANCE 2/EORTC trial 1410 randomized phase II study on Depatux –M alone, Depatux-M in combination with temozolomide (TMZ) and either TMZ or lomustine (LOM) in recurrent EGFR amplified glioblastoma (NCT02343406).Org: Erasmus MC Cancer Center, Rotterdam, Netherlands Cancer Institute, Erasmus MC Cancer Institute, University Medical Center, Department of Hematology, Rotterdam, Netherlands, Fondazione IRCCS Istituto Neurologico Carlo Besta,
Abstract
Patient-derived skin MicroOrganoSpheres and clinical response to immunotherapy.Org: Xilis, Durham Veteran Affairs Medical Center, NC Medical Research, Xilis Inc, Xilis, Inc.,
Abstract
A phase III study of lurbinectedin alone or in combination with irinotecan vs investigator's choice (topotecan or irinotecan) in patients with relapsed small cell lung cancer (SCLC; LAGOON trial).Org: Institut Gustave Roussy, Villejuif, France, Hospital Universitario 12 de Octubre, Madrid, Spain, Spain,
Abstract
Comparison of response from RECIST1.1 and abstraction in real-world patients with lung cancer.Org: Genentech, Inc., Brigham and Women’s Hospital, Harvard Medical School, F. Hoffmann-La Roche Ltd,
Abstract
Effect of multi-targeting bacterial gene therapy on tumour regression and survival in mouse models of ovarian and intraperitoneal cancer.Org: Aurealis Therapeutics, Kuopio University Hospital, Finland, Basel, Switzerland, Switzerland,
Abstract
A SYSTEM FOR RAPID GENERATION OF RECOMBINANT ADENOVIRUSES BY LIGATIONOrg: Rheumatology, Cardiology Unit, IRCCS Humanitas Research Hospital, Rozzano (Milano), Italy, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland, Switzerland,
Abstract
A FINANCIAL IMPACT ASSESSMENT OF INTRODUCING LUMIRACOXIB ONTO THE FORMULARY OF THE UK NATIONAL HEALTH SERVICE FOR THE MANAGEMENT OF PATIENTS WITH OSTEOARTHRITISOrg: Health Economics and Health Services Research, Cerner LifeSciences, Beverly Hills Cancer Care, Novartis Pharmaceuticals Corporation, East Hanover, NJ,
Abstract
AN EASY FUNCTIONAL CAPACITY EVALUATION IN CHRONIC LOW BACK PAIN Org: DalCor Pharmaceuticals, CHUV, Lausanne, Switzerland, Switzerland,
Abstract
ARTICULAR MANIFESTATIONS OF POLYMYOSITIS WITH ANTI-SYNTHETASE SYNDROMEOrg: Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Bichat Hospital, Medecine interne, Claude Huriez Hospitals, Lille University Hospital, Lille, France, Pitié Salpétrière,
Abstract
BENEFITS OF A MULTIDISCIPLINARY PROGRAM FOR FIBROMYALGIAOrg: Rheumatology Division, Division of Clinical Pharmacology and Toxicology, Geneva University Hospitals, SRL, Swiss League Against Rheumatism, Zurich,